Upregulation of GRP78 and GRP94 and Its function in chemotherapy resistance to VP-16 in human lung cancer cell line SK-MES-1

Cancer Investigation

Volumn 27, Issue 4, 2009, Pages 453-458

  Zhang, Lichuan ^a,b   Wang, Siyan ^b   Wangtao, ^a   Wang, Yanyan ^b   Wang, Jiarui ^b   Jiang, Li ^b   Li, Sheng ^b   Hu, Xiujuan ^c   Wang, Qi ^b  

^a DALIAN UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c Department of Respiratory Medicine   (China)

Author keywords

GRP78; GRP94; Human lung cancer cell line sk mes 1; Resistance; VP 16

Indexed keywords

CALCIMYCIN; ETOPOSIDE; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; RNA; ANTINEOPLASTIC AGENT; CHAPERONE; ENDOPLASMIN; HEAT SHOCK PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; MOLECULAR CHAPERONE GRP78;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING; CANCER STEM CELL; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CALCIMYCIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MOLECULAR CHAPERONES; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 65249102905     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802527239     Document Type: Article

References (37)

1. Parkin, D.M.; Bray, R; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2), 74-108.
2. Lee, A.S. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 2001, 26(8), 504-510.
3. Yong, R; Amy, S.L. Glucose regulated protein in cancer progression, drug resistance and immunotherapy. Cancer Biol. Ther. 2006, 5(7), 741-744.
4. Mazzarella, R.A.; Green, M. ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homologous to 90 kDa heat shockprotein (hsp90) and the 94 kDa glucose-regulated protein (GRP94). J Biol Chem 1987, 262(18), 8875-8879.
5. Yang, Y; Li, Z. Roles of heat shock protein grp96 in the ER quality control: redundant or unique function? Mol Cells 2005,20(2), 173- 182.
6. Lee, A.S. Mammalian stress response: induction of the glucose- regulated protein family. CurrOpin Cell Biol 1992, 4(2), 267-273.
7. Little, E.; Ramakrishnan, M.; Roy, B.; Gazit, G.; Lee, A.S. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Exp 1994, 4(1), 1-18.
8. Rupert, L.; Feith, M.; Rudiger Siewert, J.; Wester, H.-J.; Hoefler, H. Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer 2008, 8,70.
9. Wang, Q.; He, Z.; Zhang, J.; Wang, Y; Wang, T; Tong, S.; Wang, L.; Wang, S.; Chen, Y. Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance. Cancer Detect. Prevent. 2005, 29(6), 544-551.
10. Jianze, L; Lee, A.S. Stress induction of GRP78/Bip and its role in cancer. Curr Mol Med 2006, 6(1), 45-50.
11. Koumenis, C. ER stress, hypoxia tolerance, and tumorprogression. Curr Mol Med 2006, 6(1), 55-69.
12. Sutherland, R.M. Cell and environment interactions in tumor mi- croregions: the multicell spheroid model. Science 1988,240,177- 184.
13. Haas, I.G.; Wabl, M. Immunoglobulin heavy chain binding protein. Nature 1983, 306, 387-389.
14. Gazit, G.; Lu, J.; Lee, A.S. De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat 1999, 54(2), 135-146.
15. Li, L.J.; Li, X.; Ferrario, A.; Rucker, N.; Liu, E.S.; Wong, S.; Gomer, C.J.; Lee, A.S. Establishment of a Chinese hamster ovary cell line that expresses grp78 antisense transcripts and suppresses A23187 induction of both GRP78 and GRP94. J Cell Physiol 1992, 753(3), 575-582.
16. Jamora, C; Dennert, G.; Lee, A.S. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc Natl Acad Sci USA 1996, 93(15), 7690- 7694.
17. Pyrko, P.; Shonthal, A.H.; Hofman, F.M.; Chen, T.C.; Lee, A.S. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 2007, Oct 15, 67(20), 9809-9816.
18. 2+-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide- induced apoptosis. J Biol Chem 1999, 274(40), 28476-28483.
19. Rao, R.V.; Peel, A.; Logvinova, A.; del Rio, G.; Hermel, E.; Yokota, T.; Goldsmith, PC; Ellerby, L.M.; Ellerby, H.M.; Bredesen, D.E. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 2002, 574(2-3), 122- 128.
20. Reddy, R.K.; Mao, C; Baumeister, P.; Austin, R.C.; Kaufman, R.J.; Lee, A.S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 2003, 278(23), 20915-20924.
21. Lee, A.S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007 Apr 15, 67(8), 3496-3499.
22. Wang, Q.; Wang, T; Wang, Y; Wang, W.; Wang, Y; Hu, X.; Shao, S.; Zhang, J.; Suo, Z. VP-16 resistance in the NCI-H460 human lung cancer cell line is significantly associated with glucose- regulated protein78 (GRP78) induction. Anticancer Res 2007, 27(4B), 2359-2364.
23. Pirozynski, M. 100 years of lung cancer. Respir Med 2006 Dec, 700(12), 2073-2084.
24. Reiko, I.; Masaomi, N.; Hiroshi, 0.; Hiroshi, U.; Yasuko, K.; Kiyokazu, N.; Ogawa, S.; Kurokawa, K.; Couser, W.G.; Miyata, T. Involvement of endoplasmic reticulum (ER) stress in podocyte injury induced by excessive protein accumulation. Kidney Int 2005, 68(6), 2639-2650.
25. 2+ATPase inhibitor thapsigargin. J Biol Chem 1993, 263(16), 12003-12009.
26. Lee, A.S. Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biochem Sci 1987, 72, 20-23.
27. Chatterjee, S.; Cheng, M.F.; Berger, R.B.; Berger, S.J.; Berger, N.A. Effect of inhibitors of poly (ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide. Cancer Res 1995, 55(4), 868-873.
28. Dong, D.Z.; Ko, B.; Baumeister, P.; Swenson, S.; Costa, E; Mark- land, F.; Stiles, C; Patterson, J.B.; Bates, S.E.; Lee, A.S. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res 2005, 65(13), 5785-5791.
29. Kubota, H.; Suzuki, T.; Lu, J.; Takahashi, S.; Sugita, K.; Sekiya, S.; Suzuki, N. Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines. Int J Radiat Biol 2005, 81(9), 701-709.
30. Herzog, T.J. Recurrent ovarian cancer: how important is it to treat to disease progression? Clin Cancer Res 2004, 75(10), 7439-7449.
31. Hande, KR. Etoposide: four decades of development of a topoiso- merase II inhibitor. Eur J Cancer 1998, 34(10), 1514-1521.
32. Gosky, D.; Chatterjee, S. Down-regulation of topoisomerase II is caused by up-regulation of GRP78. Biochem Biophys Res Com- mun 2003, 300(2), 327-332.
33. Rao, R.V.; Hermel, E.; Castro-Obregon, S.; del Rio, G.; Ellerby, L.M.; Ellerby, H.M.; Bredesen, D.E. Coupling endoplasmic reticulum stress to the cell death program: mechanism of caspase activation. J Biol Chem 2001, 276(36), 33869-33874.
34. Fu, Y; Li, J.; Lee, A.S. GRP78/BJP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen- starvation induced apoptosis. Cancer Res 2007, 67(8), 3734- 3740.
35. Brewer, J.W.; Hendershot, L.M.; Sherr, C.J.; Diehl, J.A. Mammalian unfolded protein response inhibits cyclin D1 translation and cell- cycle progression. Proc Natl Acad Sci USA 1999 Jul 2, 96(15), 8505-8510.
36. Tomida, A.; Tsuruo, T. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des1999, 74(2), 169-177.
37. Ying-Yan, W.; Tao, W.; Xin, L; Hong-Wei, G.; Bing-Cheng, L; Qi, W. The analysis of chemotherapy resistance in human lung cancer cell line with microchip-based system. Biomed Microdevices 2008, 70(3), 429-435.